World's Best Scientists 2026 revealed!
Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Medicine

D-Index
121
Citations
119177
World Ranking
3515
National Ranking
70

Research.com Recognitions

  • 2023 - Research.com Medicine in Sweden Leader Award

Overview

Hans Wedel is affiliated with the Nordic School of Public Health in Sweden. The primary focus of their research lies in Medicine, particularly within the subfields of Endocrinology, Diabetes and Metabolism, Genetics, Nephrology, Obstetrics and Gynecology, and Dermatology.

The main research topics Hans Wedel has contributed to include:

  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Diabetic Foot Ulcer Assessment and Management
  • Diabetes and Associated Disorders
  • Chronic Kidney Disease and Diabetes
  • Gestational Diabetes Research and Management
  • Skin Diseases and Diabetes

Hans Wedel has published extensively across multiple reputable venues, with frequent publications in:

  • Diabetes
  • Diabetologia
  • The Lancet Regional Health - Europe
  • Acta Diabetologica

Selected recent papers authored or co-authored by Hans Wedel include:

  • "Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry," 2021, Diabetologia
  • "Risk factors, mortality trends, and cardiovascular diseases in people with Type 1 diabetes and controls in Sweden: An observational cohort study," 2022, The Lancet Regional Health - Europe
  • "Risk factors for nephropathy in persons with type 1 diabetes: a population-based study," 2022, Acta Diabetologica
  • "527-P: Risk Factors for Nephropathy among Children and Young Adults with Type 1 Diabetes: A Swedish Cohort," 2020, Diabetes
  • "52-OR: Risk Factors and Incidence over Time for Lower Extremity Amputations in Persons with Type 1 Diabetes: An Observational Cohort Study of 46,008 Patients from the Swedish National Diabetes Registry," 2021, Diabetes

Hans Wedel's frequent collaborators include:

  • Marcus Lind
  • Ann-Marie Svensson
  • Aldina Pivodic
  • Sara Hallström
  • Johnny Ludvigsson

Best Publications

  • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial

    Lennart Hansson;Alberto Zanchetti;S George Carruthers;Björn Dahlöf

  • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Björn Dahlöf;Richard B Devereux;Sverre E Kjeldsen;Stevo Julius

  • Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

    S. Sans;A. Menotti;G. De Backer;D. De Bacquer

  • Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery

    L. Sjöström;A.-K. Lindroos;M. Peltonen

  • Effects of bariatric surgery on mortality in Swedish obese subjects.

    Lars Sjöström;Kristina Narbro;C. David Sjöström;Kristjan Karason

  • Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

    Deborah Marshall;Olof Johnell;Hans Wedel

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  • Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

    Björn Dahlöf;Peter S Sever;Neil R Poulter;Hans Wedel

  • Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year

    Klas Malmberg;Lars Rydén;Suad Efendic;Johan Herlitz

  • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Lars H Lindholm;Hans Ibsen;Björn Dahlöf;Richard B Devereux

  • Rosuvastatin in Older Patients with Systolic Heart Failure

    John Kjekshus;Eduard Apetrei;Vivencio Barrios;Michael Böhm

  • Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

    A. Hjalmarson;S. Goldstein;B. Fagerberg;H. Wedel

  • Bariatric Surgery and Long-term Cardiovascular Events

    Lars Sjöström;Markku Peltonen;Peter Jacobson;C. David Sjöström

  • Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity

    K Malmberg;Lars Rydén;H Wedel;K Birkeland

  • Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

    Å Hjalmarson;Johan Herlitz;I Málek;L Rydén

  • Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

    Karl Swedberg;Peter Held;John Kjekshus;Knut Rasmussen

  • Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Infarction Long-Term Results From the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study

    Klas Malmberg;Anna Norhammar;Hans Wedel;Lars Rydén

  • Association of Bariatric Surgery With Long-term Remission of Type 2 Diabetes and With Microvascular and Macrovascular Complications

    Lars Sjöström;Markku Peltonen;Peter Jacobson;Sofie Ahlin

  • Intense Metabolic Control by Means of Insulin in Patients With Diabetes Mellitus and Acute Myocardial Infarction (DIGAMI 2): Effects on Mortality and Morbidity

    K. Malmberg;L. Rydén;H. Wedel

Frequent Co-Authors

Lars Wilhelmsen
Lars Wilhelmsen University of Gothenburg
Björn Dahlöf
Björn Dahlöf Sahlgrenska University Hospital
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Markku S. Nieminen
Markku S. Nieminen University of Helsinki
John Kjekshus
John Kjekshus University of Oslo
Peter S. Sever
Peter S. Sever Imperial College London
Neil R. Poulter
Neil R. Poulter Imperial College London
Richard B. Devereux
Richard B. Devereux Cornell University
Suzanne Oparil
Suzanne Oparil University of Alabama at Birmingham
Ulf de Faire
Ulf de Faire Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring additional healthcare degrees online can open up a variety of career options. For those interested in mental health, psych np programs offer specialized training to become a Psychiatric Nurse Practitioner. These programs are ideal for nurses who want to focus on mental wellness and psychiatric care.

Healthcare administration is another fast-growing field. If you’re looking for a management or leadership role, consider pursuing one of the cheapest mha programs online. These affordable degrees prepare students for high-level positions in hospitals, clinics, or healthcare organizations.

For further cost-effective options, explore other cheap mha programs that balance quality with affordability, making career advancement more accessible.

For those aiming for the highest clinical and leadership roles in nursing, the cheapest dnp programs offer a flexible path to a Doctor of Nursing Practice. These programs are designed for working nurses seeking to advance their expertise without putting their careers on hold.

Best Scientists Citing Hans Wedel

Trending Scientists

Recently Published Articles